Improving Clinical Decision Making with Engaging CME, Tools, & Resources
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Diagnostic Vitrectomy for Infectious Uveitis
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Kimberly Cockerham, MD
Designing Efficient Clinic Workflows for TED Therapy Access
Overcoming Real-World Barriers to TED Treatment
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Why Staging TED Correctly Matters Even When CAS Is Low
Applying CAS, EUGOGO, VISA: A Micro Case
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Vitreous Sensing Vitrectomy
Maria Berrocal
Jordan D. Deaner, MD
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.